Literature DB >> 16329080

Selection of patients with hepatocellular carcinoma for liver transplantation.

R Sutcliffe1, D Maguire, B Portmann, M Rela, N Heaton.   

Abstract

BACKGROUND: Orthotopic liver transplantation (OLT) plays a pivotal role in the management of selected patients with initial hepatocellular carcinoma (HCC). After disappointing early results and a shortage of cadaveric grafts, patients are currently selected for OLT on the basis of tumour size and number. Limitations of these criteria and the advent of living donation have prompted their re-evaluation. The principal aims of this review were to define the limitations of current transplant criteria for HCC, and to identify potential areas for improvement.
METHODS: A Medline search using the terms 'liver transplantation' and 'hepatocellular carcinoma' was conducted. Additional references were sourced from key articles. RESULTS AND
CONCLUSION: In patients with HCC, biological properties of the tumour are more accurate than radiological criteria in determining outcome after transplantation. Despite the risks of tumour biopsy, which may have been previously overstated, histological evaluation before transplantation may have a role and warrants further study. By expanding the donor pool and eliminating waiting times, live donor liver transplantation is a valuable resource that has yet to fulfil its potential because of unresolved ethical issues concerning the safety of the donor. The availability of long-term outcome data may help to clarify this in the near future. Copyright 2005 British Journal of Surgery Society Ltd.

Entities:  

Mesh:

Year:  2006        PMID: 16329080     DOI: 10.1002/bjs.5198

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  11 in total

Review 1.  Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review.

Authors:  Nicola de'Angelis; Filippo Landi; Maria Clotilde Carra; Daniel Azoulay
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

2.  Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation.

Authors:  Kathy Han; George N Tzimas; Jeffrey S Barkun; Peter Metrakos; Jean L Tchervenkov; Nir Hilzenrat; Phil Wong; Marc Deschênes
Journal:  Can J Gastroenterol       Date:  2007-01       Impact factor: 3.522

3.  Optimal treatment for hepatocellular carcinoma in the cirrhotic liver.

Authors:  S A White; D M Manas; S G Farid; K R Prasad
Journal:  Ann R Coll Surg Engl       Date:  2009-10       Impact factor: 1.891

Review 4.  Liver transplantation for hepatocellular carcinoma.

Authors:  Sudeep Tanwar; Shahid A Khan; Vijay Paul Bob Grover; Catherine Gwilt; Belinda Smith; Ashley Brown
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

5.  Selection of treatment modality for hepatocellular carcinoma according to the modified Japan Integrated Staging score.

Authors:  Atsushi Nanashima; Junichi Masuda; Satoshi Miuma; Yorihisa Sumida; Takashi Nonaka; Kenji Tanaka; Shigekazu Hidaka; Terumitsu Sawai; Takeshi Nagayasu
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

Review 6.  Liver transplantation: yesterday, today and tomorrow.

Authors:  Osman Abbasoglu
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

7.  Liver resection for hepatocellular carcinoma in a hepatitis B endemic area.

Authors:  Adam St J R Bartlett; John L McCall; Jonathan B Koea; Andrew Holden; Mee-Ling Yeong; Nishanthi Gurusinghe; Ed Gane
Journal:  World J Surg       Date:  2007-07-04       Impact factor: 3.352

8.  The survival benefit of liver transplantation for hepatocellular carcinoma patients with hepatitis B virus infection and cirrhosis.

Authors:  Qing Zhang; Xinguo Chen; Yunjin Zang; Li Zhang; Hong Chen; Letian Wang; Yujian Niu; Xiuyun Ren; Zhongyang Shen; Lei Shang
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

9.  Diagnostic Value of Preoperative Needle Biopsy for Tumor Grading Assessment in Hepatocellular Carcinoma.

Authors:  Lijun Wang; Jianguo Wang; Xuanyu Zhang; Jie Li; Xuyong Wei; Jun Cheng; Qi Ling; Haiyang Xie; Lin Zhou; Xiao Xu; Shusen Zheng
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

10.  Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.

Authors:  Qing Zhang; Yong-Lin Deng; Chang Liu; Li-Hong Huang; Lei Shang; Xin-Guo Chen; Le-Tian Wang; Jin-Zan Du; Ying Wang; Pei-Xiao Wang; Hui Zhang; Zhong-Yang Shen
Journal:  World J Gastroenterol       Date:  2016-11-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.